Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

40.17
+0.22000.55%
Post-market: 40.170.00000.00%19:30 EDT
Volume:765.29K
Turnover:30.70M
Market Cap:3.87B
PE:-20.54
High:41.48
Open:40.20
Low:39.58
Close:39.95
52wk High:42.68
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:1.08
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.23
PE(LYR):-31.26

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Nuvalent, Sirius XM, J.M. Smucker

Reuters
·
Jun 09

BUZZ-IDEAYA Biosciences drops on $300 mln equity raise

Reuters
·
Jun 09

IDEAYA Biosciences Shares Down 8.6% Premarket After Co Announces Pricing of $300 Mln Stock Offering

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences - Shares Priced at $27 Each

THOMSON REUTERS
·
Jun 09

BRIEF-Ideaya Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Jun 09

Ideaya Biosciences Plans $300 Million Public Offering

MT Newswires Live
·
Jun 09

Ideaya Biosciences announces $300M common stock offering

TIPRANKS
·
Jun 09

IDEAYA Biosciences plans public offering of up to $300 million in common stock, pre-funded warrants

Reuters
·
Jun 09

IDEAYA Biosciences - to Grant Underwriters 30-Day Option to Purchase up to $45 Mln of Common Stock

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences - Announces Proposed Public Offering of up to $300 Mln in Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences files Form 3 for Chief Development Officer Theodora Ross

Reuters
·
Jun 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: IDEAYA Biosciences (IDYA) and Diaceutics (OtherDIUXF)

TIPRANKS
·
Jun 04

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
Jun 03

Ideaya Biosciences Teams With Roche to Test Combination Therapy in Pancreatic Cancer

MT Newswires Live
·
Jun 03

Ideaya Biosciences announces IDE892 collaboration with Roche

TIPRANKS
·
Jun 03

IDEAYA Biosciences, Roche collaborate on IDE892-RG6505 combo study in MTAP-deleted RAS-mutant pancreatic cancer

Reuters
·
Jun 03

IDEAYA Biosciences Announces Clinical Collaboration With Roche in Mtap-Deleted Ras-Mutant Pancreatic Cancer

THOMSON REUTERS
·
Jun 03

IDEAYA Biosciences - Co and Roche Retain All Commercial Rights to Their Respective Compounds

THOMSON REUTERS
·
Jun 03

IDEAYA Biosciences - to Sponsor Clinical Trial With Joint Governance With Roche

THOMSON REUTERS
·
Jun 03